Thank you for your participation in the IDEAYA Biosciences Ocular Ad Board taking place at the Sheraton Palo Alto Hotel in Palo Alto, CA on Thursday, November 12, 2026, from 3:30 pm to 7:30 pm PST.
This program will bring together a select group of experts to share insights, discuss key considerations, and provide strategic guidance to help inform ongoing medical and scientific planning. Your perspective and expertise are highly valued, and we look forward to a productive and engaging discussion.
The objectives of the meeting are:
- Review and discuss key findings from OptimUM-01, OptimUM-02, and OptimUM-09, including remaining evidence gaps and opportunities for data communication.
- Assess the emerging uveal melanoma data presented at ESMO and potential implications on the evolving treatment landscape.
- Identify best practices for referral pathways, multidisciplinary collaboration, and patient monitoring between ocular and medical oncology teams for primary and metastatic uveal melanoma.
Please use this site to confirm your registration, get information and support on travel, and review the meeting details.